Cormedix (CRMD.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec18

CorMedix Announces Positive Mid-Term Results for DefenCath Real-World Study in Hemodialysis Patients

13:02

Nov12

Cormedix released FY2025 9 Months earnings on November 12 Pre-Market (EST), actual revenue USD 183.09 M, actual EPS USD 1.8399

14:30

Cormedix released FY2025 Q3 earnings on November 12 Pre-Market (EST), actual revenue USD 104.28 M (forecast USD 86.02 M), actual EPS USD 1.2599 (forecast USD 0.6342)

14:30

Nov5

Cormedix to Release FY2025 Q3 Earnings on November 12, Pre-Market EST; Forecast Revenue USD 86.02 M, EPS USD 0.6342

00:21

Oct22

Ruiz Analyzes and Recommends Healthcare Sector Stocks

10:06

Oct21

Timashev Maintains Strong Buy Rating for Cormedix with $19.33 Price Target

10:57

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 104.28 M, Net Income 108.56 M, EPS 1.2599

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 39.74 M, Net Income 19.83 M, EPS 0.28

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 39.08 M, Net Income 20.64 M, EPS 0.2999

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More